Cumberland Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Cumberland Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Cumberland Pharmaceuticals Inc Strategy Report
- Understand Cumberland Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View up-to-date information on Cumberland Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20240024481A1 | Application | Injectable ibuprofen formulation | A61J1/065; A61J1/10; A61K31/192; A61K47/02; A61P29/00 | January 25, 2024 |
| US20240024411A1 | Application | Methods for the prevention or treatment of anthrax infection | A61K38/14; A61P31/04 | January 25, 2024 |
| US20230381147A1 | Application | Ifetroban treatment for systemic sclerosis | A61K31/422; A61K47/02; A61K9/0019; A61K9/0053; A61K9/2059; A61K9/4858; A61P37/00; A61P5/00 | November 30, 2023 |
| ES2955158T3 | Grant | Composiciones y métodos de tratamiento de la distrofia muscular con antagonistas del receptor de tromboxano-a2 | A61K31/422; A61P1/00; A61P1/04; A61P21/00; A61P21/04; A61P9/00; A61P9/10 | November 29, 2023 |
| US11806400B2 | Grant | Injectable ibuprofen formulation | A61J1/065; A61J1/10; A61K31/192; A61K47/02; A61P29/00; A61P9/00 | November 07, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer